 Metabolic Syndrome X
"Metabolic Syndrome X" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A cluster of metabolic risk factors for CARDIOVASCULAR DISEASES and TYPE 2 DIABETES MELLITUS. The major components of metabolic syndrome X include excess ABDOMINAL FAT; atherogenic DYSLIPIDEMIA; HYPERTENSION; HYPERGLYCEMIA; INSULIN RESISTANCE; a proinflammatory state; and a prothrombotic (THROMBOSIS) state. (from AHA/NHLBI/ADA Conference Proceedings, Circulation 2004; 109:551-556)
| Descriptor ID |
D024821
|
| MeSH Number(s) |
C18.452.394.968.500.570 C18.452.625
|
| Concept/Terms |
Metabolic Syndrome X- Metabolic Syndrome X
- Insulin Resistance Syndrome X
- Syndrome X, Metabolic
- Syndrome X, Insulin Resistance
- Metabolic X Syndrome
- Syndrome, Metabolic X
- X Syndrome, Metabolic
- Dysmetabolic Syndrome X
- Syndrome X, Dysmetabolic
- Reaven Syndrome X
- Syndrome X, Reaven
- Metabolic Cardiovascular Syndrome
- Cardiovascular Syndrome, Metabolic
- Cardiovascular Syndromes, Metabolic
- Syndrome, Metabolic Cardiovascular
|
Below are MeSH descriptors whose meaning is more general than "Metabolic Syndrome X".
Below are MeSH descriptors whose meaning is more specific than "Metabolic Syndrome X".
This graph shows the total number of publications written about "Metabolic Syndrome X" by people in this website by year, and whether "Metabolic Syndrome X" was a major or minor topic of these publications.
To see the data from this visualization as text, click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2002 | 1 | 0 | 1 | | 2003 | 1 | 0 | 1 | | 2007 | 1 | 0 | 1 | | 2009 | 1 | 0 | 1 | | 2012 | 1 | 0 | 1 | | 2013 | 1 | 0 | 1 | | 2014 | 0 | 1 | 1 |
To return to the timeline, click here.
Below are the most recent publications written about "Metabolic Syndrome X" by people in Profiles.
-
Hamilton MT, Hamilton DG, Zderic TW. Sedentary behavior as a mediator of type 2 diabetes. Med Sport Sci. 2014; 60:11-26.
-
Tomassoni D, Nwankwo IE, Gabrielli MG, Bhatt S, Muhammad AB, Lokhandwala MF, Tayebati SK, Amenta F. Astrogliosis in the brain of obese Zucker rat: a model of metabolic syndrome. Neurosci Lett. 2013 May 24; 543:136-41.
-
Lee DC, Sui X, Church TS, Lavie CJ, Jackson AS, Blair SN. Changes in fitness and fatness on the development of cardiovascular disease risk factors hypertension, metabolic syndrome, and hypercholesterolemia. J Am Coll Cardiol. 2012 Feb 14; 59(7):665-72.
-
Dey D, Wong ND, Tamarappoo B, Nakazato R, Gransar H, Cheng VY, Ramesh A, Kakadiaris I, Germano G, Slomka PJ, Berman DS. Computer-aided non-contrast CT-based quantification of pericardial and thoracic fat and their associations with coronary calcium and Metabolic Syndrome. Atherosclerosis. 2010 Mar; 209(1):136-41.
-
Hamilton MT, Hamilton DG, Zderic TW. Role of low energy expenditure and sitting in obesity, metabolic syndrome, type 2 diabetes, and cardiovascular disease. Diabetes. 2007 Nov; 56(11):2655-67.
-
Miller AR, Etgen GJ. Novel peroxisome proliferator-activated receptor ligands for Type 2 diabetes and the metabolic syndrome. Expert Opin Investig Drugs. 2003 Sep; 12(9):1489-500.
-
Etgen GJ, Oldham BA, Johnson WT, Broderick CL, Montrose CR, Brozinick JT, Misener EA, Bean JS, Bensch WR, Brooks DA, Shuker AJ, Rito CJ, McCarthy JR, Ardecky RJ, Tyhonas JS, Dana SL, Bilakovics JM, Paterniti JR, Ogilvie KM, Liu S, Kauffman RF. A tailored therapy for the metabolic syndrome: the dual peroxisome proliferator-activated receptor-alpha/gamma agonist LY465608 ameliorates insulin resistance and diabetic hyperglycemia while improving cardiovascular risk factors in preclinical models. Diabetes. 2002 Apr; 51(4):1083-7.
|
People  People who have written about this concept. _
Similar Concepts
People who have written about this concept.
_
Top Journals
Top journals in which articles about this concept have been published.
|